Control apoe level for treating fetal alcohol spectrum disorders
AssigneeChildren's National Medical Center
InventorsKazue Hashimoto-Torii, Hye Hwang, Masaaki Torii
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods for treating or alleviating a fetal alcohol spectrum disorder (FASD) in a subject, the method comprising administering to the subject an effective amount of an apolipoprotein E (APOE)-modulating therapeutic, thereby treating or alleviating the FASD.
Claims22
A method for treating or alleviating a fetal alcohol spectrum disorder (FASD) in a subject, the method comprising administering to the subject an effective amount of an apolipoprotein E (APOE)-modulating therapeutic, thereby treating or alleviating the FASD.
A method for treating or alleviating an FASD in a subject, the method comprising administering to the subject an effective amount of an APOE-mimetic therapeutic, thereby treating or alleviating the FASD.
A method of increasing APOE activity in a subject, the method comprising administering to the subject an effective amount of an APOE-modulating therapeutic, thereby increasing APOE activity, wherein the subject has or is suspected of having PAE.
Dependencies are inferred from the claim text.